top of page

.png)
CLEPIC 2026
The CLEPIC 2025 was organized in collaboration between the Josep Carreras Leukaemia Research Institute and International Society for Molecular and Clinical Epigenetics (iSMOCLEP).

Heads of local organizing committee

Manel Esteller and José L. Sardina.
Heads of local organizing committee
Dear Colleagues,
We are delighted to invite you to the 5th International Clinical Epigenetics Conference (CLEPIC2026), taking place June 10–12, 2026 in Badalona (Barcelona), Spain. Organized by the International Society for Molecular and Clinical Epigenetics and the Josep Carreras Leukaemia Research Institute, in collaboration with Clinical Epigenetics and Epigenetics Communications (Springer Nature), CLEPIC2026 will gather leading experts, clinicians, and industry innovators to share the latest advances in molecular and clinical epigenetics, with a special focus on cancer epigenetics. Attendees will also have the unique opportunity to meet editors of two of the field’s most influential journals.
The conference will be hosted at the Josep Carreras Leukaemia Research Institute, on the scenic Can Ruti Biomedical Campus, with panoramic views of the sparkling Mediterranean Sea and the rolling forested mountains of the Serralada de Marina. The venue sits within the Barcelona metropolitan area—one of the largest biomedical hubs in Southern Europe—offering a perfect blend of cutting-edge science and Mediterranean lifestyle.
Beyond the sessions, enjoy world-class Catalan cuisine, relax on golden beaches, and explore Barcelona’s extraordinary architecture— from Gothic landmarks to the modernist masterpieces of Antoni Gaudí, including the world-famous Sagrada Família. Stroll vibrant streets, take in the art, and experience the city’s unique energy.
We look forward to welcoming you to a conference where science meets culture, collaboration, and the Mediterranean spirit. Please mark your calendars for June 10–12, 2026 and join us for an inspiring and unforgettable experience.
CLEPIC2026 PROGRAM
bottom of page
















